Ambeed.cn

首页 / / / STAT / HO-3867

HO-3867 {[allProObj[0].p_purity_real_show]}

货号:A909125

HO-3867是一种选择性抑制 STAT3 磷酸化和转录的化合物,是姜黄素的类似物。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
HO-3867 化学结构 CAS号:1172133-28-6
HO-3867 化学结构
CAS号:1172133-28-6
HO-3867 3D分子结构
CAS号:1172133-28-6
HO-3867 化学结构 CAS号:1172133-28-6
HO-3867 3D分子结构 CAS号:1172133-28-6
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

HO-3867 纯度/质量文件 产品仅供科研

货号:A909125 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 STAT1 STAT3 STAT5 其他靶点 纯度
Nifuroxazide 98%
Fludarabine 98%
Artesunate 98%
BP-1-102 +++

STAT3, Kd: 504 nM

99%+
Niclosamide ++

STAT3, IC50: 0.7 μM

98%
Napabucasin 98%
Cryptotanshinone ++

STAT3, IC50: 4.6 μM

98%
Stattic +

STAT3, IC50: 5.1 μM

98%
NSC 74859 +

STAT3, IC50: 86 μM

99%+
Ochromycinone 98%
HO-3867 97%
C188-9 ++++

STAT3, Kd: 4.7 nM

99%+
HJC0152 99%
SH5-07 95%
SH-4-54 ++++

STAT3, Kd: 300 nM

+++

STAT5, Kd: 464 nM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

HO-3867 生物活性

靶点
  • STAT3

描述 HO-3867, a curcumin analogue, is a selective STAT3 inhibitor. It selectively inhibited STAT3 phosphorylation, transcription, and DNA binding without affecting the expression of other active STATs at 10μM. HO-3867 significantly inhibited BRCA-mutated ovarian cancer cells expressing higher level of Tyrosine-phosphorylated STAT3 (pTyr705) in vitro, in a dose (1-20μM)- and time (12-48h)-dependent manner, with apoptosis shown by elevated levels of cleaved caspase-3, caspase-7 and PARP. Also, treatment with HO-3867 resulted in decreased expression of pTyr705 and its downstream targets cyclin D1, Bcl-2 and surviving in these cells. HO-3867 is a safe STAT3 Inhibitor for it exhibited minimal toxicity toward noncancerous cells and tissues but induced apoptosis in ovarian cancer cells. It inhibited cell migration/invasion and survival of primary human ovarian cancer cells isolated from patient ascites at 10μM post 24h. Administration of HO-3867 at 100ppm could block xenograft tumor growth without toxic side effects in nude mice injected with A2780 cells.
作用机制 HO-3867 has high affinity for a pocket located on the DNA-binding domain of the STAT3 and it could interact with both the STAT3 dimer and monomer structures.[1]

HO-3867 细胞实验

Cell Line
Concentration Treated Time Description References
CHO cells 10 µM 24 hours HO-3867 exhibited minimal toxicity toward normal cells Cancer Res. 2014 Apr 15;74(8):2316-27.
Ishikawa (IK) cells 5 µM 24 hours Inhibition of EV secretion and EC cell proliferation Oncogene. 2024 Nov;43(49):3586-3597.
Leishmania donovani promastigotes 1-200 µg/ml 2 hours HO-3867 induced oxidative stress-mediated apoptosis in L. donovani promastigotes, characterized by altered cell morphology, phosphatidylserine externalization, mitochondrial depolarization, intracellular lipid accumulation, and cell cycle arrest. Front Cell Infect Microbiol. 2021 Dec 3;11:774899.
Leishmania major promastigotes 1-200 µg/ml 2 hours HO-3867 induced dose-dependent apoptosis in L. major promastigotes. Front Cell Infect Microbiol. 2021 Dec 3;11:774899.
A2780 human epithelial ovarian cancer cells 10 µM 24 hours To evaluate the inhibitory effect of HO-3867 on the STAT3 signaling pathway and its impact on cancer cell apoptosis. Results showed that HO-3867 significantly reduced the phosphorylation levels of STAT3 and induced apoptosis in cancer cells. Free Radic Biol Med. 2010 May 1;48(9):1228-35.
HSMC human aortic smooth muscle cells 10 µM 24 hours To evaluate the effect of HO-3867 on the viability of noncancerous cells. Results showed that HO-3867 was significantly less toxic to HSMC cells compared to cancer cells. Free Radic Biol Med. 2010 May 1;48(9):1228-35.
OVTOKO cells 5 µM and 10 µM 24 hours Treatment with HO-3867 decreased expression of pSTAT3 Tyr705 as well pSTAT3 Ser727, while total STAT3 remained constant. Int J Cancer. 2017 Nov 1;141(9):1856-1866.
JHOC cells 5 µM and 10 µM 24 hours Treatment with HO-3867 decreased expression of pSTAT3 Tyr705 as well pSTAT3 Ser727, while total STAT3 remained constant. Int J Cancer. 2017 Nov 1;141(9):1856-1866.
A2780 cells 10 µM 24 hours HO-3867 induced G2/M cell-cycle arrest in A2780 cells by modulating cell-cycle regulatory molecules p53, p21, p27, cdk2 and cyclin, and promoted apoptosis by caspase-8 and caspase-3 activation. Mol Cancer Ther. 2010 May;9(5):1169-79.
SKOV3 cells 10 µM 24 hours HO-3867 significantly inhibited the proliferation of SKOV3 cells and induced apoptosis. Mol Cancer Ther. 2010 May;9(5):1169-79.
OVCAR3 cells 10 µM 24 hours HO-3867 significantly inhibited the proliferation of OVCAR3 cells and induced apoptosis. Mol Cancer Ther. 2010 May;9(5):1169-79.
U2OS cells 2, 4, 8, 16, 32 µM 24 hours HO-3867 significantly reduced the viability of U2OS cells and induced apoptosis Pharmaceutics. 2022 Jun 13;14(6):1257.
HOS cells 2, 4, 8, 16, 32 µM 24 hours HO-3867 significantly reduced the viability of HOS cells and induced apoptosis Pharmaceutics. 2022 Jun 13;14(6):1257.
MG-63 cells 2, 4, 8, 16, 32 µM 24 hours HO-3867 significantly reduced the viability of MG-63 cells and induced apoptosis Pharmaceutics. 2022 Jun 13;14(6):1257.
Ishikawa cells 5 and 10 µM 24 hours HO-3867 significantly decreased the expression of pSTAT3 Ser727 while total STAT3 remained constant; cell viability decreased by 50–80% and induced G2/M arrest in 55% of Ishikawa cells at the G2/M cell cycle checkpoint. Gynecol Oncol. 2014 Oct;135(1):133-41.
Human oral squamous cell carcinoma SCC-9 cells 0, 2.5, 5, 10, and 20 µM 24 hours To evaluate the effect of HO-3867 on SCC-9 cell growth, results showed that HO-3867 effectively suppressed SCC-9 cell growth. J Cell Mol Med. 2022 Apr;26(8):2273-2284.
Human oral squamous cell carcinoma HSC-3 cells 0, 2.5, 5, 10, and 20 µM 24 hours To evaluate the effect of HO-3867 on HSC-3 cell growth, results showed that HO-3867 effectively suppressed HSC-3 cell growth. J Cell Mol Med. 2022 Apr;26(8):2273-2284.
A195 cells 10 µM 24-72 hours HO-3867 significantly suppressed the survival of A195 cells Oncogene. 2017 Jan 12;36(2):168-181.
Ishikawa cells 5 and 10 µM 3 and 6 hours HO-3867 selectively induced G2/M cell-cycle arrest in Ishikawa cells in a dose and time-dependent manner, with the greatest increase in G2/M cell population at 6 hours. Gynecol Oncol. 2014 Oct;135(1):133-41.
A2780 cells 10 µM 3 hours HO-3867 inhibited STAT3 nuclear translocation Cancer Res. 2014 Apr 15;74(8):2316-27.
Human pulmonary artery smooth muscle cells 0.5 µM and 1 µM 48 and 72 hours To study the effect of HO-3867 on peroxynitrite-induced cell proliferation, results showed that HO-3867 is capable of scavenging peroxynitrite and inhibiting peroxynitrite-induced smooth muscle cell proliferation. Hypertension. 2013 Mar;61(3):593-601.
HUVEC cells 5 µM and 10 µM HO-3867 significantly inhibited formation of capillary-like structures and invasion in HUVEC cells. Int J Cancer. 2017 Nov 1;141(9):1856-1866.
Murine macrophages 100 µg/ml HO-3867 was completely safe for normal murine macrophages. Front Cell Infect Microbiol. 2021 Dec 3;11:774899.

HO-3867 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Rats Left-heart failure-induced pulmonary hypertension model Dietary administration 100 ppm Continued for 4 weeks To study the effect of HO-3867 on left-heart failure-induced pulmonary hypertension, results showed that HO-3867 significantly attenuated the increase in pulmonary artery pressure and inhibited vascular remodeling by restoring PTEN activity. Hypertension. 2013 Mar;61(3):593-601.
C57BL/6 mice High-fat diet-induced endometrial hyperplasia model Oral 2 mg/kg 8 weeks Inhibition of high-fat diet-induced endometrial hyperplasia and EV secretion Oncogene. 2024 Nov;43(49):3586-3597.
BALB/c Nude mice Ovarian cancer xenograft model Oral 25, 50, 100 ppm Once daily for 35 days HO-3867 significantly inhibited the growth of the ovarian xenografted tumors in a dosage-dependent manner without any apparent toxicity. Mol Cancer Ther. 2010 May;9(5):1169-79.
BALB/c Nude mice Endometrial cancer xenograft model Oral 50 and 100 ppm Continuous for 4 weeks HO-3867 significantly inhibited the growth of xenograft endometrial tumors and induced apoptosis in vivo. Gynecol Oncol. 2014 Oct;135(1):133-41.
Mice Orthotopic ovarian cancer model Oral 50 and 100ppm Once daily for 6 weeks HO-3867 significantly suppressed ovarian tumor growth, angiogenesis, and metastasis Oncogene. 2017 Jan 12;36(2):168-181.
Nude mice A2780cDDP xenograft model Oral 50 or 100 ppm 28 days HO-3867 significantly inhibited tumor growth without toxic side effects Cancer Res. 2014 Apr 15;74(8):2316-27.

HO-3867 动物研究

Dose Mice: 20 mg/kg[3] (i.v.) Rat: 10 mg/kg, 25 mg/kg[4] (i.p.)
Administration i.v., i.p.

HO-3867 参考文献

[1]Rath KS, Naidu SK, et al. HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer. Cancer Res. 2014 Apr 15;74(8):2316-27.

[2]Tierney BJ, McCann GA, et al. HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells. Cancer Biol Ther. 2012 Jul;13(9):766-75.

[3]Madan E, Parker TM, et al. The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53. J Biol Chem. 2018 Mar 23;293(12):4262-4276.

[4]Dayton A, Selvendiran K, et al. Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties. Cancer Biol Ther. 2010 Nov 15;10(10):1027-32.

HO-3867 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.15mL

0.43mL

0.22mL

10.76mL

2.15mL

1.08mL

21.53mL

4.31mL

2.15mL

HO-3867 技术信息

CAS号1172133-28-6
分子式C28H30F2N2O2
分子量 464.55
SMILES Code O=C1/C(CN(CC2=CC(C)(C)N(O)C2(C)C)C/C1=C\C3=CC=C(F)C=C3)=C/C4=CC=C(F)C=C4
MDL No. MFCD28143913
别名
运输蓝冰
InChI Key PWZQFTQMMAIRRM-JFMUQQRKSA-N
Pubchem ID 46871899
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Inert atmosphere, store in freezer, under -20°C

溶解方案

DMSO: 30 mg/mL(64.58 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。